Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
- PMID: 29102432
- DOI: 10.1016/S2213-8587(17)30325-X
Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
Abstract
Follicular thyroid cancer is the second most common differentiated thyroid cancer histological type and has been overshadowed by its more common counterpart-papillary thyroid cancer-despite its unique biological behaviour and less favourable outcomes. In this Review, we comprehensively review the literature on follicular thyroid cancer to provide an evidence-based guide to the management of these tumours, to highlight the lack of evidence behind guideline recommendations, and to identify changes and challenges over the past decades in diagnosis, prognosis, and treatment. We highlight that correct identification of cancer in indeterminate cytological samples is challenging and ultrasonographic features can be misleading. Despite certain unique aspects of follicular thyroid cancer presentation and prognosis, no specific recommendations exist for follicular thyroid cancer and Hürthle cell carcinoma in evidence-based guidelines. Efforts should be made to stimulate additional research in this field.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?Diagn Cytopathol. 2006 May;34(5):330-4. doi: 10.1002/dc.20440. Diagn Cytopathol. 2006. PMID: 16604553
-
Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.Eur J Surg Oncol. 2018 Mar;44(3):338-347. doi: 10.1016/j.ejso.2017.05.002. Epub 2017 May 18. Eur J Surg Oncol. 2018. PMID: 28554832 Free PMC article. Review.
-
Well-differentiated carcinoma of the thyroid.Otolaryngol Clin North Am. 2003 Feb;36(1):73-90, viii. doi: 10.1016/s0030-6665(02)00127-5. Otolaryngol Clin North Am. 2003. PMID: 12803010 Review.
-
Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.Thyroid. 2009 Apr;19(4):355-60. doi: 10.1089/thy.2008.0338. Thyroid. 2009. PMID: 19355826
-
Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.Cancer Cytopathol. 2016 Oct;124(10):729-736. doi: 10.1002/cncy.21741. Epub 2016 Jun 20. Cancer Cytopathol. 2016. PMID: 27322887
Cited by
-
Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.Endocrine. 2021 Apr;72(1):179-189. doi: 10.1007/s12020-020-02445-8. Epub 2020 Aug 8. Endocrine. 2021. PMID: 32770440
-
Clinical-Pathological Features of Thyroid Neoplasms in Young Patients Diagnosed in a Single Center.Life (Basel). 2024 May 28;14(6):696. doi: 10.3390/life14060696. Life (Basel). 2024. PMID: 38929679 Free PMC article.
-
The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases.Int J Biol Sci. 2021 Apr 17;17(7):1731-1741. doi: 10.7150/ijbs.55381. eCollection 2021. Int J Biol Sci. 2021. PMID: 33994857 Free PMC article. Review.
-
Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):449-460. doi: 10.1007/s00259-020-04952-2. Epub 2020 Jul 18. Eur J Nucl Med Mol Imaging. 2021. PMID: 32683470 Free PMC article.
-
Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.Drug Des Devel Ther. 2021 Oct 11;15:4275-4287. doi: 10.2147/DDDT.S322502. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34703209 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous